⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 5, 2025Science Immunology

It’s getting hot in here: Heating up the tumor microenvironment with an oral HO-1 inhibitor

Cait A. McAlindon Rachael A. Clark

View Full Paper

Ask AI

Bookmark

Share

Key Points

Enhancing tumor clearance occurs with the use of an oral ho-1 inhibitor in a mouse model.
The study reports significant recruitment of cd8 t cells, aiding in tumor elimination post-chemotherapy.
The methodology involved testing the inhibitor on mice following chemotherapy administration.
The findings suggest that oral ho-1 inhibitors may improve chemotherapy outcomes, necessitating further exploration.

Implication

Research demonstrates improved tumor clearance and cd8 t cell recruitment in mice, implying enhanced chemotherapy effectiveness.

Abstract

A new orally bioavailable HO-1 inhibitor enhances tumor clearance after chemotherapy in mice by enhancing the recruitment of CD8 T cells.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

McAlindon et al. (2025) studied this question.

synapsesocial.com/papers/68c193f19b7b07f3a06181cb https://doi.org/10.1126/sciimmunol.aeb8328

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1An oral heme oxygenase inhibitor targets immunosuppressive perivascular macrophages in preclinical models of cancer2025 · 4 citations
2Abstract 5847: Development of a selective haem oxygenase-1 inhibitor for the immunotherapy treatment of cancerIn Vitro Study · 2026
3The Diverse Roles of Heme Oxygenase-1 in Tumor ProgressionReview · 2021 · 152 citations
4Heme Oxygenase-1-Targeted Cancer Therapy: At the Crossroads of Cytoprotection and Tumour Progression2025
5Antitumor Effects of PD-1 Blockade Combined with Mild Hyperthermia in a Murine Osteosarcoma ModelOriginal Research · 2026 · 1 citations